GALECTO BIOTECH ApS: Financial statements 2025
CVR: 34878366
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2025. In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. That is a decrease of 81% compared with the year before. Equity in the 2025 report amounted to EUR 7,844,625. The solvency ratio was 96.8%. The company had 37 employees in the financial year.
- Gross Profit
- EUR 1,039,275
- Profit/Loss
- EUR -709,079
- Equity
- EUR 7,844,625
- Total Assets
- EUR 8,106,932
- Employees
- 37
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1 mio. EUR | -709 t. EUR | 7.8 mio. EUR | 37 |
| 2024 | - | 5.5 mio. EUR | 310 t. EUR | 8.6 mio. EUR | 36 |
| 2023 | - | 15.3 mio. EUR | 849 t. EUR | 8.2 mio. EUR | 29 |
| 2022 | - | 12.3 mio. EUR | 819 t. EUR | 7.4 mio. EUR | 36 |
| 2021 | - | 9.4 mio. EUR | 765 t. EUR | 3.7 mio. EUR | 29 |
Official annual report
How creditworthy is GALECTO BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GALECTO BIOTECH ApS has published its annual report for 2024. Gross profit came to DKK 5,477,168, and the net result was DKK 310,297.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.